Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2007
06/27/2007CN1985944A Chinese medicine composition for treating cutaneous pruritus, rubella and other diseases
06/27/2007CN1985941A Preparing method of micropill of six Chinese medicine materials including glutinous rehmannia
06/27/2007CN1985934A Medicine for treating hepatitis B and its preparing method
06/27/2007CN1985933A preparing method of gentian capsule for purging liver fire
06/27/2007CN1985932A Combined Chinese medicine for treating gastric ulcer
06/27/2007CN1985928A Medicine for treating hepatopathy
06/27/2007CN1985927A Medicine composition for treating hepatic disease mainly
06/27/2007CN1985926A Compound kudzu vine root two purpose health beverage used as sauce and vinegar and medicine
06/27/2007CN1985924A Compound Chinese medicine preparation for catharsis and its preparing process
06/27/2007CN1985914A Plaster for treating diarrhea and its preparing method
06/27/2007CN1985910A Plaster for treating constipation and its preparing method
06/27/2007CN1985902A Chinese medicine for treating chronic hepatopathy
06/27/2007CN1985900A Colon-targeting oral compound rubarb preparation
06/27/2007CN1985891A Compound Chinese medicine preparation with liver protecting function and its preparing process
06/27/2007CN1985890A Process of preparing schisandra granule
06/27/2007CN1985885A Medicine for treating viral dysentery
06/27/2007CN1985880A Chinese herbal medicine for treating gastrointestinal diseases and hemophilia
06/27/2007CN1985879A Diarrhea treating plaster and its preparing method
06/27/2007CN1985878A Medicine composition for treating peptic ulcer and its preparing method
06/27/2007CN1985877A Astragalus extract and its medicine use
06/27/2007CN1985873A Medicine composition of glycyrrhizic acid or its salt, ginseng and astragalus root
06/27/2007CN1985872A Preparing method and application of blattbulume soft capsule preparation
06/27/2007CN1985871A Chinese medicine preparation for preventing and treating chronic liver fibrosis and cirrhosis
06/27/2007CN1985868A Medicine for treating stomatocace
06/27/2007CN1985864A Medicine composition of glycyrrhizic acid or its salt, ginseng and glossy ganoderma
06/27/2007CN1985855A Ginkgo health vinegar recipe and preparing method
06/27/2007CN1985854A Plant lactobacillus composition and its application in strengthening intestinal immunobarrier
06/27/2007CN1985844A Preparing process of magnetic adsorbent and its application in treating hyperbilirubinemia
06/27/2007CN1985838A Lung-targeting tylan microsphere for animal and birds and its preparing method
06/27/2007CN1985830A Lung-targeting ofloxacin microsphere for animal and birds and its preparing method
06/27/2007CN1985829A Stammering treating medicine and its preparing method
06/27/2007CN1985822A Enteric omeprazole micropill and its preparing method
06/27/2007CN1985812A Lung-targeting florfenicol microsphere for animal and birds and its preparing method
06/27/2007CN1985626A Spleen and stomach invigorating antidiarrheal porridge
06/27/2007CN1323154C Longevity medicinal wine and preparing method thereof
06/27/2007CN1322898C Small interference RNA molecule SiRNA capable of attacking human hepatitis B virus and application thereof
06/27/2007CN1322897C Use of IL-18 inhibitors
06/27/2007CN1322890C Medicine for treating gastric ulcer
06/27/2007CN1322873C Medicine for treating child diarrhea and its preparing method
06/27/2007CN1322869C Bioactive snow-frong oil lecithin powder and its preparation
06/27/2007CN1322865C Oral colon-positioned medicine composition for curing bacillary dysentery
06/27/2007CN1322860C Levo carnitine dropping pill and preparation thereof
06/26/2007US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation
06/26/2007US7235656 Anxiolytic agents with reduced sedative and ataxic effects
06/26/2007US7235635 IRAK-4: compositions and methods of use
06/26/2007US7235634 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
06/26/2007US7235628 Analogues of GLP-1
06/26/2007US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis
06/26/2007US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout
06/26/2007US7235552 Cholenic acid amides and pharmaceutical compositions thereof
06/26/2007US7235550 Polycyclic azaindole compounds
06/26/2007US7235549 Benzamide, heteroarylamide and reverse amides
06/26/2007US7235523 Methods for the treatment of hepatic disorders
06/26/2007US7235241 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone
06/26/2007CA2235686C Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them
06/26/2007CA2215372C Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
06/26/2007CA2185037C Iridaceae extract and compositions containing the same
06/21/2007WO2007069671A1 Bicyclic heterocyclic compound
06/21/2007WO2007069635A1 Vla-4 inhibitory drug
06/21/2007WO2007069565A1 Bicyclic heterocyclic compound
06/21/2007WO2007069368A1 Peptides originating in hepatitis c virus
06/21/2007WO2007068829A1 Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine
06/21/2007WO2007068739A1 4-amino-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, neurological and cardiovascular disorders
06/21/2007WO2007068462A2 Mtor inhibitors for the treatment of inflammatory bowel disease
06/21/2007WO2007068171A1 CRYSTALLINE FORM I OF 3,4',5-TRIHYDROXY-STIBENE-3-β-D-GLUCOSIDE
06/21/2007WO2007068058A1 Hyper immune bovine colostrum gastrointestinal vaccine
06/21/2007WO2007068055A1 A method for preventing reduced feed intake in animals and treatment of disease conditions
06/21/2007WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
06/21/2007US20070143871 Non-human transgenic animal models for hepatocellular carcinoma
06/21/2007US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors
06/21/2007US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate
06/21/2007US20070142465 Macrophage activation inhibitor
06/21/2007US20070142449 Angiogenesis inhibitors
06/21/2007US20070142427 Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
06/21/2007US20070142419 Thienyl Compounds
06/21/2007US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity
06/21/2007US20070142342 Pharmaceutical compounds
06/21/2007US20070142340 Steroids as agonists for FXR
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/21/2007US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
06/21/2007US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade
06/21/2007US20070142291 Methods for treating irritable bowel syndrome
06/21/2007US20070142275 for the treatment of diseases and pathological alterations associated with excessive or deregulated TGF- beta 1 expression
06/21/2007US20070141184 Composition for oral administration containing capsaicinoids
06/21/2007US20070141173 Medicament comprising noble metal fine particles
06/21/2007US20070141137 Stable capsule preparation
06/21/2007US20070141083 Use of a single-cell protein material
06/21/2007US20070141039 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome
06/21/2007US20070140988 Therapeutic agent for periodontal disease
06/21/2007US20070140987 Promoting whole body health
06/21/2007US20070140975 Opioid formulations having reduced potential for abuse
06/21/2007DE102005062160A1 Aktivkohle für die medizinische Verwendung Activated carbon for medical use
06/20/2007EP1798229A1 Substituted biphenyl derivative
06/20/2007EP1798227A1 Serotonin 5-ht3 receptor agonist
06/20/2007EP1798226A1 Triazole derivative
06/20/2007EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound
06/20/2007EP1797889A1 Activated carbon for medical use
06/20/2007EP1797858A1 Composition for oral cavity
06/20/2007EP1797171A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs)
06/20/2007EP1797089A1 Substituted tricyclic benzimidazoles
1 ... 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 ... 1258